EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models

Authors:

Abstract
No abstract available
Funding Information
  • Stichting Lymph&Co
  • Parker Institute for Cancer Immunotherapy
  • Laffey-McHugh Foundation
  • National Cancer Institute (R37-CA-262362-02)

This publication has 85 references indexed in Scilit: